Literature DB >> 19189179

Binding of IgA by Mycoplasma penetrans.

Awni Moussa1, Ran Nir-Paz, Shlomo Rottem.   

Abstract

The current study shows that Mycoplasma penetrans strain GTU binds human serum immunoglobulin A (IgA) and secretory IgA but not IgG. Binding of IgA was associated almost exclusively with the lipoprotein fraction obtained by Triton X-114 fractionation of isolated M. penetrans membranes. Western immunoblot analysis of isolated membranes of M. penetrans strain GTU and of the Triton X-114 fraction showed that the major IgA-binding component was a lipoprotein with a molecular mass of 38 kDa, one of the major lipoproteins of this organism. The authors suggest that the high IgA-binding capacity of M. penetrans strain GTU may serve as a defense mechanism, conferring on this microorganism the ability to evade clearance mediated by specific IgA antibodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189179     DOI: 10.1007/s00284-009-9359-1

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  29 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli.

Authors:  G Lindahl; B Akerström
Journal:  Mol Microbiol       Date:  1989-02       Impact factor: 3.501

3.  Binding of IgA and/or IgG is a common property among clinical isolates of group A streptococci.

Authors:  G Lindahl; L Stenberg
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

6.  Mycoplasma penetrans infections and seroconversion in patients with AIDS: identification of major mycoplasmal antigens targeted by host antibody response.

Authors:  Shyh-Ching Lo; Richard Y-H Wang; Teresa Grandinetti; Nianxiang Zou; Michael M Hayes; Jim W-K Shih; Douglas J Wear
Journal:  FEMS Immunol Med Microbiol       Date:  2005-06-01

Review 7.  Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.

Authors:  W W Navarre; O Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

8.  The cell membrane of Mycoplasma penetrans: lipid composition and phospholipase A1 activity.

Authors:  M Salman; S Rottem
Journal:  Biochim Biophys Acta       Date:  1995-05-04

9.  High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients.

Authors:  R Y Wang; J W Shih; T Grandinetti; P F Pierce; M M Hayes; D J Wear; H J Alter; S C Lo
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

10.  An unusual polar lipid from the cell membrane of Mycoplasma fermentans.

Authors:  J Deutsch; M Salman; S Rottem
Journal:  Eur J Biochem       Date:  1995-02-01
View more
  3 in total

1.  Identification of lipoprotein MslA as a neoteric virulence factor of Mycoplasma gallisepticum.

Authors:  S M Szczepanek; S Frasca; V L Schumacher; X Liao; M Padula; S P Djordjevic; S J Geary
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

2.  Mycoplasma mycoides, from "mycoides Small Colony" to "capri". A microevolutionary perspective.

Authors:  Francois Thiaucourt; Lucia Manso-Silvan; Woubit Salah; Valérie Barbe; Benoit Vacherie; Daniel Jacob; Marc Breton; Virginie Dupuy; Anne Marie Lomenech; Alain Blanchard; Pascal Sirand-Pugnet
Journal:  BMC Genomics       Date:  2011-02-16       Impact factor: 3.969

Review 3.  Beware of Mycoplasma Anti-immunoglobulin Strategies.

Authors:  Yonathan Arfi; Carole Lartigue; Pascal Sirand-Pugnet; Alain Blanchard
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.